GlaxoSmithKline PLC

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
GlaxoSmithKline PLC
TickerGSK
CIK #0001131399
CUSIP37733W105
SectorLife Sciences - Pharmaceutical Preparations
Address980 Great West Road, Brentford Middlesex, TW8 9GS
Source [EDGAR]
CIK Filing 2011 - 2024
[0001131399] 3
[0001131399] 4
[0001131399] 5
[0001131399] 6-K
[0001131399] SC 13D
[0001131399] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
GSK PLC CVRX Inc [2023-02-06] 4.9
GSK PLC Wave Life Sciences Ltd [2023-01-30] 10.95
GSK PLC 23Andme Holding Co [2022-11-04] 13.2
GSK PLC Haleon PLC [2022-07-27] 12.94
Dodge & Cox GlaxoSmithKline PLC [2022-02-14] 5.9
GlaxoSmithKline PLC Lyell Immunopharma Inc [2022-02-10] 12.6
GlaxoSmithKline PLC CVRX Inc [2021-07-12] 5.0
GlaxoSmithKline PLC F-Star Therapeutics Inc [2020-11-30] 8.9
GlaxoSmithKline PLC CureVac NV [2020-08-24] 8.4
GlaxoSmithKline PLC Pandion Therapeutics Inc [2020-08-03] 7.9
GlaxoSmithKline PLC Nkarta Inc [2020-07-22] 0.7
GlaxoSmithKline PLC VIR Biotechnology Inc [2020-05-04] 6.03
GlaxoSmithKline PLC Progyny Inc [2020-02-14] 12.5
GlaxoSmithKline PLC Fulcrum Therapeutics Inc [2020-02-14] 7.7
GlaxoSmithKline PLC Morphic Holding Inc [2019-07-12] 8.9
GlaxoSmithKline PLC Bicycle Therapeutics PLC [2019-06-07] 10.8
GlaxoSmithKline PLC Orchard Therapeutics PLC [2019-05-10] 14.5
GlaxoSmithKline PLC Turning Point Therapeutics Inc [2019-04-26] 6.7
GlaxoSmithKline PLC Genocea Biosciences Inc [2019-02-25] 12.7
GlaxoSmithKline PLC Principia Biopharma Inc [2018-09-26] 11.7
GlaxoSmithKline PLC Translate Bio Inc [2018-07-05] 8.3
GlaxoSmithKline PLC Spero Therapeutics Inc [2017-11-16] 13.3
GlaxoSmithKline PLC Aileron Therapeutics Inc [2017-07-10] 0.7
GlaxoSmithKline PLC CRISPR Therapeutics AG [2016-10-28] 8.3
GlaxoSmithKline PLC Theravance Biopharma Inc [2016-03-24] 24.3
GlaxoSmithKline PLC Theravance Biopharma Inc [2015-09-02] 24.5
GlaxoSmithKline PLC HTG Molecular Diagnostics Inc [2015-05-15] 16.12
GlaxoSmithKline PLC Concert Pharmaceuticals Inc [2015-02-13] 7.5
GlaxoSmithKline PLC Scynexis Inc [2014-05-15] 6.2
GlaxoSmithKline PLC Applied Genetic Technologies Corp [2014-04-07] 14.1
GlaxoSmithKline PLC Genocea Biosciences Inc [2014-02-14] 0.7
GlaxoSmithKline PLC OncoMed Pharmaceuticals Inc [2014-02-14] 0.4
GlaxoSmithKline PLC Xenoport Inc [2012-12-19] 8.6
GlaxoSmithKline PLC Regulus Therapeutics Inc [2012-10-10] 0.3
GlaxoSmithKline PLC Response Genetics Inc [2012-09-21] 15.2
GlaxoSmithKline PLC ChemoCentryx Inc [2012-02-23] 20.8
Form 3/4/5 Filer 2011 - 2024
Wave Life Sciences Ltd.
GSK PLC
Spero Therapeutics, Inc.
23andMe Holding Co.
Theravance Biopharma, Inc.
CVRx, Inc.
Lyell Immunopharma, Inc.
Innoviva, Inc.
Decibel Therapeutics, Inc.
BICYCLE THERAPEUTICS plc
Genocea Biosciences Inc
Pandion Therapeutics, Inc.
Nkarta, Inc.
Turning Point Therapeutics, Inc.
Progyny, Inc.
Orchard Therapeutics plc
Principia Biopharma Inc.
Fulcrum Therapeutics, Inc.
Morphic Holding, Inc.
ChemoCentryx, Inc.
Liquidia Technologies Inc
Constellation Pharmaceuticals Inc
Translate Bio, Inc.
Aileron Therapeutics Inc
HTG Molecular Diagnostics Inc
CRISPR Therapeutics AG
Applied Genetic Technologies Corp
Amicus Therapeutics Inc
Nupathe Inc
Concert Pharmaceuticals Inc
OncoMed Pharmaceuticals Inc
Response Genetics Inc
Human Genome Sciences Inc
Form 13F Holdings
Firm Period DFND Voting Shares
Kahn Brothers Group Inc [2023-03-31] SOLE 1,277,476.0 1,277,476.0
Columbia Asset Management [2023-03-31] SOLE 9,300.0 9,300.0
Paradigm Asset Management Co LLC [2023-03-31] SOLE 0.0 1,000.0
PARK CIRCLE Co [2023-03-31] SOLE 800.0 800.0
Retirement Group, LLC [2023-03-31] SOLE 0.0 283.0
Boyd Watterson Asset Management Llc/Oh [2023-03-31] SOLE 251.0 251.0
Bartlett & Co LLC [2023-03-31] SOLE 240.0 240.0
Huntington National Bank [2023-03-31] DFND 0.0 1.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com